Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erwinaze PK in Young Adults with ALL/LBL
NCT02150928Phase 2Withdrawn
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Asparaginase erwinia chrysanthemi in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by Jazz Pharmaceuticals plc. Planned start May 2014; status: withdrawn.
02
Drugs
Asparaginase erwinia chrysanthemi
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT02150928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150928.